# Celea Therapeutics

**Canonical:** https://apis.io/providers/celea-therapeutics/  
**Website:** https://www.celeatx.com  
**APIs profiled:** 0

Celea Therapeutics is a biopharmaceutical company focused on developing next‑generation therapies for serious respiratory diseases, notably idiopathic pulmonary fibrosis. Their lead program deupirfenidone is in Phase 3, aiming to become a new standard of care. The company emphasizes patient‑centric science and innovative drug development.

## Kin Score — 3.5 / 100 (minimal)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Celea Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biopharma, Respiratory, IPF, Therapeutics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/celea-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.